From New York to Toronto: the 500-mile walk that raised $750,000 for Parkinson’s research
Author: Parkinson's Life editorsPublished: 14 July 2016
Prep: Cook: Serves:
When three friends embarked on an epic 500-mile journey on foot from New York City to Toronto, they weren’t expecting the hiker who inspired the walk to travel all the way from Scotland to show his support and join them for the final leg
Five hundred miles is a long distance for anyone to walk – and it’s even more of a challenge if you’re battling Parkinson’s symptoms all the way. Yet that’s exactly what three friends – Harry McMurtry, Sue Thompson and Ross Sugar – did when they set out on a remarkable journey from New York City, US, to Harry’s hometown Toronto, Canada.
“It took all the strength I could summon to finish the walk each day, but I wouldn’t quit,” said Harry, a former lawyer who was diagnosed with early-onset Parkinson’s in 2009. “Too many people were counting on us.”
The walk, dubbed ‘500 Miles for Parkinson’s’, took nearly two months to complete, averaging 15 miles a day. The trio had set a fundraising target of $500,000. In the end, they raised a staggering total of $750,000.
The streets of Toronto were closed off by police to make way for the walk
“I would be lying if I didn’t say that this took every ounce of energy and strength I had to do this,” said Harry, who was taken to hospital when he fell during the challenging walk. “By the end, my body was ready to shut down. But I wanted to help people with Parkinson’s, so I never gave up.”
“By the end, my body was ready to shut down. But I wanted to help people with Parkinson’s, so I never gave up”
If crossing the finishing line was ever in the balance, Harry’s spirits must surely have been lifted by the many friends, relatives and celebrities who turned out to support him along the way – including a surprise trans-Atlantic visit from the man said to have inspired it all.
In 2014, John MacPhee walked the same distance on his ‘Long Straight Walk’ across England and Scotland (starting at Land’s End in Cornwall and ending at John O’Groats in the Scottish Highlands). While Harry was researching his own walk, he reached out to John for advice via the Internet – and the two became friends.
So when Harry’s support team contacted John to see if he’d come all the way from Scotland to join the last leg of the walk with Harry at the end of June, in a surprise ‘guest’ appearance, he didn’t hesitate.
John MacPhee dressed in a traditional Scottish kilt
John, from Inverness, told Parkinson’s Life: “As the end of Harry’s walk drew closer the organisers urged me to complete the walk with him – Harry’s support team was keen to keep my visit a surprise for him.”
Describing the scene as the pair met for the first time, John continued: “Harry was ready to start the penultimate walk of his epic 500-mile journey. When he saw me, a huge smile spread across his tanned face. I wasn’t quite ready for the enormous hug but I knew this was a very big surprise and judging by the tears that ran down both of our faces, it was an emotional moment.”
The three walkers and their supporters – including John – celebrated the success of the challenge at a huge fundraising gala in Toronto, which saw the auction of ice hockey shirts belonging to the famous Wayne Gretzky, raising a further US$10,000. The total sum exceeded $750,000.
Ice hockey player Wayne Gretzky’s jersey was auctioned off for $10,000
John paid tribute to the efforts of Harry and his companions: “The three walkers who made it every step of the way are giants. Harry McMurtry, Sue Thompson and Ross Sugar are real heroes.
“They proved you are most certainly not defined by this condition, you are defined by your excellence at being human beings, the people who surround you and support you are there because you make it real, you made it happen.”
500 miles for Parkinson’s proved to be a great success
This month’s top Parkinson’s disease news stories from around the globe
4 days ago
Is there a link between Parkinson’s disease and blood vessel dysfunction?
Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.
New swab test may help with Parkinson’s disease diagnosis
Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…
Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?
A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.